The US market says otherwise @imback.
Those are serious analysts who are unpacking the data and they've got more money and clout than you.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-502
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.73 |
Change
0.080(3.02%) |
Mkt cap ! $3.164B | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.73 | $2.68 | $11.41M | 4.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1834 | $2.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.73 | 5609 | 2 |
View Market Depth
| Last trade - 16.10pm 16/01/2025 (20 minute delay) ? |
| MSB (ASX) Chart |